Hints and tips:
...BlackRock and MFS Investment Management both voted against mining company Glencore’s climate plan earlier this year, new disclosures reveal. ...
...The Cybertruck is the first new Tesla vehicle since the Model Y in 2020, at a time when profits have fallen because of price cuts across its range to spur demand....
...Another was the attack last year on Australian health insurer Medibank....
...“The trial suggests that this treatment could have other benefits when being used to treat Covid, such as a faster recovery time and reduced follow-up with health services,” said Oxford’s Chris Butler, joint...
...Jan-Emmanuel De Neve, an economist at the Saïd Business School at Oxford university, says: “There is little ‘gold standard’ evidence with randomised control trials....
...Knowing a protein’s shape, for example a Y-shaped antibody, tells scientists more about what that protein’s role is....
...But sequencing company Oxford Nanopore chose to list in London last September....
...The AstraZeneca/Oxford jab would not be scrutinised before January, according to people briefed on the discussions....
...“As of today, Gilead has still not received the underlying data sets or statistical analysis plan necessary to validate the results,” it said....
...A version of this article was first published by Nikkei Asia on July 19. ©2022 Nikkei Inc. All rights reserved....
...And I take my bra off or pull the cups down and I jiggle my shoulders while saying, ‘T-h-a-n-k-y-o-u,’” she says, making her voice go jittery and giving a brief shimmy. “It’s very cute....
...That’s important for hiring and for health. But it’s about growing well.” Late to the party? Capital Group was years, if not decades, late to the ETF party....
...Overall, I’d like to see the hotel tackle some of its plans with a bit more pace....
...President Joe Biden said in August that booster doses would be generally available by September 20, but those plans were shelved after a committee of experts recommended the FDA approve boosters only for...
...One study from Oxford, published last week, found that the Pfizer shot’s efficacy declined at a faster rate than the Oxford/AstraZeneca vaccine, albeit from a higher level of effectiveness....
...AstraZeneca, Oxford and the Serum Institute declined to comment....
...A final decision by the government on its booster plan will be made once the Joint Committee on Vaccination and Immunisation, an advisory body, has made a recommendation....
...Merck expects to have 10m courses of treatment by the end of 2021, while Pfizer plans to make 180,000 courses by the end of the year and 50m in 2022....
...Next year, it plans to make 4bn doses. In contrast, AstraZeneca struggled to scale up production....
...It said that a plan for J&J vaccine recipients would be made when more data was available....
...Moderna and Pfizer’s plans for boosters are still moving in lockstep, with both companies developing vaccines tailored to the Delta variant, in case they become necessary, and submitting data on a third...
...In our early teens we hatched a plan to go to university together once I had taken a gap year and he had finished his A-levels. We were both doing well academically and set our hopes on Oxford....
...Discussions about the future of work too often focus on jargon-y terms like “asynchronous” and “holistic”....
...In an attempt to curb the spread of the virus, the Biden administration plans to begin offering booster shots this month to all Americans who originally received messenger RNA vaccines....
...But Dieter Helm, professor of economy policy at the University of Oxford, was critical of the sector’s record since privatisation in the early 1990s....
International Edition